Trial Profile
A retrospective cohort study to compare the outcomes between zotarolimus-eluting and everolimus-eluting cobalt-chromium alloy stents in diabetic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 07 Apr 2016 New trial record